The study, entitled COMET (Comparison of Operative to Medical Endocrine Therapy) for low -
risk ductal carcinoma in situ, received funding through a $ 13.4 million, five - year award from the Patient - Centered Outcomes Research Institute (PCORI), an independent, nonprofit organization authorized by Congress in 2010 to support research that enlightens health care decisions.
Not exact matches
The women who were taking fish oil when the study began had a reduced
risk of invasive
ductal carcinoma, the most common form of breast cancer.
The importance of active
ductal growth driven by estrogen has been further emphasized by the higher susceptibility of the breast to be transformed during a «high -
risk» window in the lifespan of a female encompassed between menarche and a first full - term pregnancy [5].
Methods: We combined data from two population - based case - control studies to examine the relationship between migraine and
risk of postmenopausal invasive breast cancer among 1,199
ductal carcinoma cases, 739 lobular carcinoma cases, and 1,474 controls 55 to 79 years of age.
Results: Women who reported a clinical diagnosis of migraine had reduced
risks of
ductal carcinoma (OR, 0.67; 95 % CI, 0.54 - 0.82) and lobular carcinoma (OR, 0.68; 95 % CI, 0.52 - 0.90).
These associations were primarily limited to hormone receptor — positive tumors as migraine was associated with a 0.65-fold (95 % CI, 0.51 - 0.83) reduced
risk of estrogen receptor — positive (ER +) / progesterone receptor — positive (PR +)
ductal carcinoma.